Immediate Impact
2 by Nobel laureates 76 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Annie Hung being referenced
Pegilodecakin as monotherapy or in combination with anti‐PD ‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study
2021
Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Annie Hung | 121 | 30 | 56 | 63 | 30 | 313 | |
| Guanghua Zhai | 52 | 19 | 33 | 50 | 25 | 365 | |
| Șerban Negru | 111 | 45 | 55 | 28 | 41 | 348 | |
| Michaël McCarthy | 64 | 43 | 24 | 84 | 50 | 348 | |
| Markus S. Jördens | 71 | 45 | 35 | 61 | 36 | 303 | |
| Gabriel Diem | 93 | 33 | 19 | 50 | 20 | 338 | |
| Jingjing Yan | 36 | 59 | 18 | 54 | 48 | 348 | |
| Sarah Mahmoud | 84 | 25 | 34 | 21 | 27 | 286 | |
| Brehima Diakité | 105 | 9 | 34 | 39 | 36 | 344 | |
| Laura Mazilu | 64 | 59 | 10 | 70 | 45 | 294 | |
| Hedyeh Ebrahimi | 84 | 82 | 12 | 80 | 24 | 343 |
All Works
Login with ORCID to disown or claim papers
Loading papers...